Review: Membranes for haemodialysis

Nephrology

Volumn 15, Issue 4, 2010, Pages 381-385

  Kerr, Peter G ^a   Huang, Louis ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Flux; Haemodialysis; High flux; Membranes

Indexed keywords

BETA 2 MICROGLOBULIN; CUPROPHANE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR; ARTIFICIAL MEMBRANE; BIOMATERIAL;

AMYLOIDOSIS; BIOCOMPATIBILITY; CELL MEMBRANE; COMPLEMENT ACTIVATION; DIALYSIS MEMBRANE; GEOMETRY; HOLLOW FIBER; HUMAN; IMMUNOREACTIVITY; MOLECULAR WEIGHT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION; ARTIFICIAL MEMBRANE; DEVICES; EQUIPMENT DESIGN; HISTORY; PERMEABILITY; POROSITY; RENAL REPLACEMENT THERAPY;

BIOCOMPATIBLE MATERIALS; EQUIPMENT DESIGN; HISTORY, 20TH CENTURY; HUMANS; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; PERMEABILITY; POROSITY; RENAL DIALYSIS;

EID: 77952896419     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01331.x     Document Type: Review

References (24)

1. Santoro A, Ferrari G, Francioso A et al. Ethylene-oxide and steam-sterilised polysulfone membrane in dialysis patients with eosinophilia. Int. J. Artif. Organs 1996 19 : 329 335.
2. Ronco C, Scarbardi M, Goldoni M, Brendolan A, Crepaldi C, La Greca G. Impact of spacing filaments external to hollow fibers on dialysate flow distribution and dialyzer performance. Int. J. Artif. Organs 1997 20 : 261 266.
3. Ronco C, Brendolan A, Lupi A, Metry G, Levin NW. Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int. 2000 58 : 809 817.
4. Cheung AK, Leypoldt JK. The hemodialysis membranes: A historical perspective, current state and future prospect. Semin. Nephrol. 1997 17 : 196 213.
5. Falkenhagen D, Bosch T, Brown GS et al. A clinical study of different cellulosic dialysis membranes. Nephrol. Dial. Transplant. 1987 2 : 537 545.
6. Pereira BJ, King AJ, Poutsiaka DD, Strom JA, Dinarello CA. Comparison of first use and reuse of cuprophan membranes on interleukin-1 receptor antagonist and interleukin-1 beta production by blood mononuclear cells. Am. J. Kidney Dis. 1993 22 : 288 295.
7. Wehle B, Bergstrom J, Kishimoto T, Lantz B, Levin N, Klinkmann H. Beta-2 microglobulin and granulocyte elastase. Nephrol. Dial. Transplant. 1993 8 (Suppl 2 20 24.
8. Woffindin C, Hoenich NA. Blood-membrane interactions during haemodialysis with cellulosic and synthetic membranes. Biomaterials 1988 9 : 53 7.
9. Cruz DN, de Cal M, Ronco C. Oxidative stress and anemia in chronic hemodialysis: The promise of bioreactive membranes. Contrib. Nephrol. 2008 161 : 89 98.
10. Pellicano R, Polkinghorne KR, Kerr PG. Reduction in beta 2-microglobulin with super-flux versus high-flux dialysis membranes: Results of a randomized, double-blind, crossover trial. Am. J. Kidney Dis. 2008 52 (1 93 101.
11. Hutchison CA, Bradwell AR, Cook M et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin. J. Am. Soc. Nephrol. 2009 4 : 745 754.
12. Collins DM, Lambert MB, Tannenbaum JS, Oliverio M, Schwab SJ. Tolerance of hemodialysis: A randomized prospective trial of high-flux versus conventional high-efficiency hemodialysis. J. Am. Soc. Nephrol. 1993 4 : 148 154.
13. Pertosa G, Grandaliano G, Gesualdo L, Ranieri E, Monno R, Schena FP. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes. Kidney Int. 1998 54 : 570 579.
14. Rosales LM, Schneditz D, Morris AJ, Rahmati S, Levin NW. Isothermic hemodialysis and ultrafiltration. Am. J. Kidney Dis. 2000 36 : 353 361.
15. van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int. 1991 39 : 1012 1019.
16. Woods HF, Nanadakumar M. Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol. Dial. Transplant. 2000 15 (Suppl 1 36 42.
17. Port FK, Wolfe RA, Hulbert-Shearon TE et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study. Am. J. Kidney Dis. 2001 37 : 276 286.
18. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 2002 347 : 2010 2019.
19. Cheung AK, Levin NW, Greene T et al. Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J. Am. Soc. Nephrol. 2003 14 : 3251 3263.
20. Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J. Am. Soc. Nephrol. 2009 20 : 645 654.
21. Ronco C, Feriani M, Chiaramonte S et al. Backfiltration in clinical dialysis. Nature of the phenomenon and possible solutions. Contrib. Nephrol. 1990 77 : 96 105.
22. Lonnemann G, Behme TC, Lenzner B et al. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. Kidney Int. 1992 42 : 61 8.
23. Weber V, Linsberger I, Rossmanith E, Weber C, Falkenhagen D. Pyrogen transfer across high- and low-flux hemodialysis membranes. Artif. Organs 2004 28 : 210 217.
24. Argilés A, Mourad G, Kerr PG, García M, Collins B, Demaille JG. Cells surrounding haemodialysis-associated amyloid deposits are mainly macrophages. Nephrol. Dial. Transplant. 1994 9 : 662 667.